Viewing Study NCT04514159


Ignite Creation Date: 2025-12-24 @ 2:59 PM
Ignite Modification Date: 2026-02-21 @ 6:35 AM
Study NCT ID: NCT04514159
Status: COMPLETED
Last Update Posted: 2023-02-01
First Post: 2020-08-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
Sponsor: Zeno Alpha Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose escalation View
None Phase 1 combination View
None Selective estrogen receptor degrader View
None Hormone sensitive View
None Estrogen receptor View
None Hormone receptor View